id	sid	tid	token	lemma	pos
ct-9227	1	1	seeking	seek	VERB
ct-9227	1	2	stem	stem	NOUN
ct-9227	1	3	cell	cell	NOUN
ct-9227	1	4	efficacy	efficacy	NOUN
ct-9227	1	5	œ	œ	NOUN
ct-9227	1	6	immunogenicity	immunogenicity	NOUN
ct-9227	1	7	matters	matter	NOUN
ct-9227	1	8	!	!	PUNCT
ct-9227	2	1	seeking	seek	VERB
ct-9227	2	2	stem	stem	NOUN
ct-9227	2	3	cell	cell	NOUN
ct-9227	2	4	efficacy	efficacy	NOUN
ct-9227	2	5	–	–	PUNCT
ct-9227	2	6	immunogenicity	immunogenicity	NOUN
ct-9227	2	7	matters	matter	NOUN
ct-9227	2	8	!	!	PUNCT
ct-9227	3	1	ashlee	ashlee	PROPN
ct-9227	3	2	watts	watts	PROPN
ct-9227	3	3	department	department	PROPN
ct-9227	3	4	of	of	ADP
ct-9227	3	5	large	large	ADJ
ct-9227	3	6	animal	animal	NOUN
ct-9227	3	7	clinical	clinical	ADJ
ct-9227	3	8	sciences	sciences	PROPN
ct-9227	3	9	college	college	PROPN
ct-9227	3	10	of	of	ADP
ct-9227	3	11	veterinary	veterinary	ADJ
ct-9227	3	12	medicine	medicine	NOUN
ct-9227	3	13	&	&	CCONJ
ct-9227	3	14	biomedical	biomedical	PROPN
ct-9227	3	15	sciences	sciences	PROPN
ct-9227	3	16	texas	texas	PROPN
ct-9227	3	17	a&m	a&m	PROPN
ct-9227	3	18	university	university	PROPN
ct-9227	3	19	,	,	PUNCT
ct-9227	3	20	college	college	NOUN
ct-9227	3	21	station	station	NOUN
ct-9227	3	22	,	,	PUNCT
ct-9227	3	23	tx	tx	VERB
ct-9227	3	24	abstract	abstract	ADV
ct-9227	3	25	despite	despite	SCONJ
ct-9227	3	26	hundreds	hundred	NOUN
ct-9227	3	27	of	of	ADP
ct-9227	3	28	publications	publication	NOUN
ct-9227	3	29	and	and	CCONJ
ct-9227	3	30	registered	register	VERB
ct-9227	3	31	clinical	clinical	ADJ
ct-9227	3	32	trials	trial	NOUN
ct-9227	3	33	,	,	PUNCT
ct-9227	3	34	definitive	definitive	ADJ
ct-9227	3	35	evidence	evidence	NOUN
ct-9227	3	36	of	of	ADP
ct-9227	3	37	mesenchymal	mesenchymal	NOUN
ct-9227	3	38	stem	stem	NOUN
ct-9227	3	39	cell	cell	NOUN
ct-9227	3	40	(	(	PUNCT
ct-9227	3	41	msc	msc	PROPN
ct-9227	3	42	)	)	PUNCT
ct-9227	3	43	efficacy	efficacy	NOUN
ct-9227	3	44	does	do	AUX
ct-9227	3	45	not	not	PART
ct-9227	3	46	exist	exist	VERB
ct-9227	3	47	.	.	PUNCT
ct-9227	4	1	the	the	DET
ct-9227	4	2	notion	notion	NOUN
ct-9227	4	3	that	that	SCONJ
ct-9227	4	4	mesenchymal	mesenchymal	ADJ
ct-9227	4	5	stromal	stromal	ADJ
ct-9227	4	6	cells	cell	NOUN
ct-9227	4	7	(	(	PUNCT
ct-9227	4	8	mscs	msc	NOUN
ct-9227	4	9	)	)	PUNCT
ct-9227	4	10	are	be	AUX
ct-9227	4	11	immune	immune	ADJ
ct-9227	4	12	privileged	privileged	ADJ
ct-9227	4	13	is	be	AUX
ct-9227	4	14	changing	change	VERB
ct-9227	4	15	:	:	PUNCT
ct-9227	4	16	mscs	msc	NOUN
ct-9227	4	17	constitutively	constitutively	ADV
ct-9227	4	18	express	express	VERB
ct-9227	4	19	mhci	mhci	NOUN
ct-9227	4	20	,	,	PUNCT
ct-9227	4	21	can	can	AUX
ct-9227	4	22	be	be	AUX
ct-9227	4	23	induced	induce	VERB
ct-9227	4	24	to	to	PART
ct-9227	4	25	express	express	VERB
ct-9227	4	26	mhcii	mhcii	NOUN
ct-9227	4	27	and	and	CCONJ
ct-9227	4	28	allo	allo	NOUN
ct-9227	4	29	-	-	PUNCT
ct-9227	4	30	immunization	immunization	NOUN
ct-9227	4	31	against	against	ADP
ct-9227	4	32	allogeneic	allogeneic	ADJ
ct-9227	4	33	mscs	msc	NOUN
ct-9227	4	34	has	have	AUX
ct-9227	4	35	been	be	AUX
ct-9227	4	36	documented	document	VERB
ct-9227	4	37	.	.	PUNCT
ct-9227	5	1	despite	despite	SCONJ
ct-9227	5	2	the	the	DET
ct-9227	5	3	clinical	clinical	ADJ
ct-9227	5	4	safety	safety	NOUN
ct-9227	5	5	of	of	ADP
ct-9227	5	6	allo	allo	NOUN
ct-9227	5	7	-	-	PUNCT
ct-9227	5	8	mscs	msc	NOUN
ct-9227	5	9	,	,	PUNCT
ct-9227	5	10	which	which	PRON
ct-9227	5	11	has	have	AUX
ct-9227	5	12	been	be	AUX
ct-9227	5	13	shown	show	VERB
ct-9227	5	14	exhaustively	exhaustively	ADV
ct-9227	5	15	without	without	ADP
ct-9227	5	16	evidence	evidence	NOUN
ct-9227	5	17	for	for	ADP
ct-9227	5	18	acute	acute	ADJ
ct-9227	5	19	rejection	rejection	NOUN
ct-9227	5	20	reactions	reaction	NOUN
ct-9227	5	21	or	or	CCONJ
ct-9227	5	22	local	local	ADJ
ct-9227	5	23	tissue	tissue	NOUN
ct-9227	5	24	inflammation	inflammation	NOUN
ct-9227	5	25	,	,	PUNCT
ct-9227	5	26	immune	immune	ADJ
ct-9227	5	27	recognition	recognition	NOUN
ct-9227	5	28	and	and	CCONJ
ct-9227	5	29	rejection	rejection	NOUN
ct-9227	5	30	occurs	occur	VERB
ct-9227	5	31	with	with	ADP
ct-9227	5	32	a	a	DET
ct-9227	5	33	reduction	reduction	NOUN
ct-9227	5	34	in	in	ADP
ct-9227	5	35	msc	msc	PROPN
ct-9227	5	36	efficacy	efficacy	NOUN
ct-9227	5	37	,	,	PUNCT
ct-9227	5	38	we	we	PRON
ct-9227	5	39	have	have	AUX
ct-9227	5	40	demonstrated	demonstrate	VERB
ct-9227	5	41	localized	localized	ADJ
ct-9227	5	42	tissue	tissue	NOUN
ct-9227	5	43	inflammation	inflammation	NOUN
ct-9227	5	44	secondary	secondary	ADJ
ct-9227	5	45	to	to	ADP
ct-9227	5	46	immune	immune	ADJ
ct-9227	5	47	recognition	recognition	NOUN
ct-9227	5	48	of	of	ADP
ct-9227	5	49	allomscs	allomsc	NOUN
ct-9227	5	50	.	.	PUNCT
ct-9227	6	1	we	we	PRON
ct-9227	6	2	have	have	AUX
ct-9227	6	3	also	also	ADV
ct-9227	6	4	demonstrated	demonstrate	VERB
ct-9227	6	5	localized	localized	ADJ
ct-9227	6	6	tissue	tissue	NOUN
ct-9227	6	7	inflammation	inflammation	NOUN
ct-9227	6	8	secondary	secondary	ADJ
ct-9227	6	9	to	to	ADP
ct-9227	6	10	immune	immune	ADJ
ct-9227	6	11	recognition	recognition	NOUN
ct-9227	6	12	of	of	ADP
ct-9227	6	13	fetal	fetal	ADJ
ct-9227	6	14	bovine	bovine	NOUN
ct-9227	6	15	serum	serum	NOUN
ct-9227	6	16	contaminants	contaminant	NOUN
ct-9227	6	17	to	to	ADP
ct-9227	6	18	mscs	msc	NOUN
ct-9227	6	19	.	.	PUNCT
ct-9227	7	1	this	this	DET
ct-9227	7	2	localized	localized	ADJ
ct-9227	7	3	tissue	tissue	NOUN
ct-9227	7	4	inflammation	inflammation	NOUN
ct-9227	7	5	supports	support	VERB
ct-9227	7	6	the	the	DET
ct-9227	7	7	clinical	clinical	ADJ
ct-9227	7	8	relevance	relevance	NOUN
ct-9227	7	9	of	of	ADP
ct-9227	7	10	allo	allo	NOUN
ct-9227	7	11	-	-	PUNCT
ct-9227	7	12	recognition	recognition	NOUN
ct-9227	7	13	of	of	ADP
ct-9227	7	14	mhc	mhc	PROPN
ct-9227	7	15	mismatched	mismatch	VERB
ct-9227	7	16	mscs	msc	NOUN
ct-9227	7	17	and	and	CCONJ
ct-9227	7	18	fbs	fbs	X
ct-9227	7	19	contaminated	contaminate	VERB
ct-9227	7	20	mscs	msc	NOUN
ct-9227	7	21	,	,	PUNCT
ct-9227	7	22	despite	despite	SCONJ
ct-9227	7	23	the	the	DET
ct-9227	7	24	lack	lack	NOUN
ct-9227	7	25	of	of	ADP
ct-9227	7	26	clinically	clinically	ADV
ct-9227	7	27	apparent	apparent	ADJ
ct-9227	7	28	adverse	adverse	ADJ
ct-9227	7	29	reaction	reaction	NOUN
ct-9227	7	30	.	.	PUNCT
ct-9227	8	1	these	these	DET
ct-9227	8	2	findings	finding	NOUN
ct-9227	8	3	may	may	AUX
ct-9227	8	4	explain	explain	VERB
ct-9227	8	5	why	why	SCONJ
ct-9227	8	6	definitive	definitive	ADJ
ct-9227	8	7	proof	proof	NOUN
ct-9227	8	8	of	of	ADP
ct-9227	8	9	msc	msc	PROPN
ct-9227	8	10	efficacy	efficacy	PROPN
ct-9227	8	11	has	have	AUX
ct-9227	8	12	not	not	PART
ct-9227	8	13	been	be	AUX
ct-9227	8	14	achieved	achieve	VERB
ct-9227	8	15	.	.	PUNCT
ct-9227	9	1	keywords	keyword	NOUN
ct-9227	9	2	:	:	PUNCT
ct-9227	9	3	equine	equine	NOUN
ct-9227	9	4	,	,	PUNCT
ct-9227	9	5	bone	bone	NOUN
ct-9227	9	6	marrow	marrow	NOUN
ct-9227	9	7	,	,	PUNCT
ct-9227	9	8	mesenchymal	mesenchymal	NOUN
ct-9227	9	9	,	,	PUNCT
ct-9227	9	10	stem	stem	NOUN
ct-9227	9	11	,	,	PUNCT
ct-9227	9	12	stromal	stromal	ADJ
ct-9227	9	13	,	,	PUNCT
ct-9227	9	14	regenerative	regenerative	ADJ
ct-9227	9	15	lameness	lameness	NOUN
ct-9227	9	16	is	be	AUX
ct-9227	9	17	one	one	NUM
ct-9227	9	18	of	of	ADP
ct-9227	9	19	the	the	DET
ct-9227	9	20	leading	lead	VERB
ct-9227	9	21	reasons	reason	NOUN
ct-9227	9	22	for	for	ADP
ct-9227	9	23	suffering	suffering	NOUN
ct-9227	9	24	and	and	CCONJ
ct-9227	9	25	ill	ill	ADJ
ct-9227	9	26	health	health	NOUN
ct-9227	9	27	in	in	ADP
ct-9227	9	28	the	the	DET
ct-9227	9	29	horse	horse	NOUN
ct-9227	9	30	,	,	PUNCT
ct-9227	9	31	and	and	CCONJ
ct-9227	9	32	it	it	PRON
ct-9227	9	33	is	be	AUX
ct-9227	9	34	estimated	estimate	VERB
ct-9227	9	35	that	that	SCONJ
ct-9227	9	36	approximately	approximately	ADV
ct-9227	9	37	60	60	NUM
ct-9227	9	38	%	%	NOUN
ct-9227	9	39	of	of	ADP
ct-9227	9	40	lameness	lameness	NOUN
ct-9227	9	41	is	be	AUX
ct-9227	9	42	due	due	ADJ
ct-9227	9	43	to	to	ADP
ct-9227	9	44	osteoarthritis	osteoarthritis	NOUN
ct-9227	9	45	.	.	PUNCT
ct-9227	10	1	mesenchymal	mesenchymal	ADJ
ct-9227	10	2	stem	stem	NOUN
ct-9227	10	3	cells	cell	NOUN
ct-9227	10	4	(	(	PUNCT
ct-9227	10	5	mscs	msc	NOUN
ct-9227	10	6	)	)	PUNCT
ct-9227	10	7	are	be	AUX
ct-9227	10	8	a	a	DET
ct-9227	10	9	regenerative	regenerative	ADJ
ct-9227	10	10	therapy	therapy	NOUN
ct-9227	10	11	used	use	VERB
ct-9227	10	12	to	to	PART
ct-9227	10	13	mitigate	mitigate	VERB
ct-9227	10	14	chronic	chronic	ADJ
ct-9227	10	15	pain	pain	NOUN
ct-9227	10	16	and	and	CCONJ
ct-9227	10	17	slow	slow	VERB
ct-9227	10	18	the	the	DET
ct-9227	10	19	progression	progression	NOUN
ct-9227	10	20	of	of	ADP
ct-9227	10	21	osteoarthritis	osteoarthritis	NOUN
ct-9227	10	22	.	.	PUNCT
ct-9227	11	1	in	in	ADP
ct-9227	11	2	people	people	NOUN
ct-9227	11	3	,	,	PUNCT
ct-9227	11	4	there	there	PRON
ct-9227	11	5	are	be	VERB
ct-9227	11	6	fda	fda	PROPN
ct-9227	11	7	non	non	PROPN
ct-9227	11	8	-	-	ADJ
ct-9227	11	9	cross	cross	ADJ
ct-9227	11	10	matched	match	VERB
ct-9227	11	11	allogenic	allogenic	NOUN
ct-9227	11	12	(	(	PUNCT
ct-9227	11	13	non	non	ADJ
ct-9227	11	14	-	-	NOUN
ct-9227	11	15	self	self	NOUN
ct-9227	11	16	)	)	PUNCT
ct-9227	11	17	and	and	CCONJ
ct-9227	11	18	autologous	autologous	ADJ
ct-9227	11	19	(	(	PUNCT
ct-9227	11	20	self	self	NOUN
ct-9227	11	21	)	)	PUNCT
ct-9227	11	22	msc	msc	PROPN
ct-9227	11	23	trials	trial	NOUN
ct-9227	11	24	for	for	ADP
ct-9227	11	25	joint	joint	ADJ
ct-9227	11	26	disease	disease	NOUN
ct-9227	11	27	and	and	CCONJ
ct-9227	11	28	approximately	approximately	ADV
ct-9227	11	29	half	half	NOUN
ct-9227	11	30	of	of	ADP
ct-9227	11	31	all	all	DET
ct-9227	11	32	current	current	ADJ
ct-9227	11	33	msc	msc	PROPN
ct-9227	11	34	clinical	clinical	ADJ
ct-9227	11	35	trials	trial	NOUN
ct-9227	11	36	in	in	ADP
ct-9227	11	37	people	people	NOUN
ct-9227	11	38	are	be	AUX
ct-9227	11	39	allogenic.1	allogenic.1	PROPN
ct-9227	11	40	this	this	PRON
ct-9227	11	41	is	be	AUX
ct-9227	11	42	because	because	SCONJ
ct-9227	11	43	allogenic	allogenic	ADJ
ct-9227	11	44	mscs	msc	NOUN
ct-9227	11	45	have	have	AUX
ct-9227	11	46	been	be	AUX
ct-9227	11	47	long	long	ADV
ct-9227	11	48	considered	consider	VERB
ct-9227	11	49	non	non	ADJ
ct-9227	11	50	-	-	ADJ
ct-9227	11	51	immunogenic	immunogenic	ADJ
ct-9227	11	52	,	,	PUNCT
ct-9227	11	53	and	and	CCONJ
ct-9227	11	54	are	be	AUX
ct-9227	11	55	more	more	ADV
ct-9227	11	56	easily	easily	ADV
ct-9227	11	57	commercialized	commercialize	VERB
ct-9227	11	58	.	.	PUNCT
ct-9227	12	1	this	this	PRON
ct-9227	12	2	remains	remain	VERB
ct-9227	12	3	true	true	ADJ
ct-9227	12	4	in	in	ADP
ct-9227	12	5	horses	horse	NOUN
ct-9227	12	6	as	as	ADV
ct-9227	12	7	well	well	ADV
ct-9227	12	8	,	,	PUNCT
ct-9227	12	9	and	and	CCONJ
ct-9227	12	10	several	several	ADJ
ct-9227	12	11	groups	group	NOUN
ct-9227	12	12	maintain	maintain	VERB
ct-9227	12	13	the	the	DET
ct-9227	12	14	feasibility	feasibility	NOUN
ct-9227	12	15	of	of	ADP
ct-9227	12	16	allogenic	allogenic	PROPN
ct-9227	12	17	msc	msc	PROPN
ct-9227	12	18	use.2,3	use.2,3	PROPN
ct-9227	12	19	however	however	ADV
ct-9227	12	20	,	,	PUNCT
ct-9227	12	21	as	as	SCONJ
ct-9227	12	22	clinical	clinical	ADJ
ct-9227	12	23	data	datum	NOUN
ct-9227	12	24	accumulate	accumulate	VERB
ct-9227	12	25	,	,	PUNCT
ct-9227	12	26	it	it	PRON
ct-9227	12	27	appears	appear	VERB
ct-9227	12	28	there	there	PRON
ct-9227	12	29	is	be	VERB
ct-9227	12	30	greater	great	ADJ
ct-9227	12	31	variability	variability	NOUN
ct-9227	12	32	in	in	ADP
ct-9227	12	33	efficacy	efficacy	NOUN
ct-9227	12	34	of	of	ADP
ct-9227	12	35	allogeneic	allogeneic	ADJ
ct-9227	12	36	therapies	therapy	NOUN
ct-9227	12	37	as	as	ADP
ct-9227	12	38	compared	compare	VERB
ct-9227	12	39	to	to	ADP
ct-9227	12	40	autologous	autologous	ADJ
ct-9227	12	41	,	,	PUNCT
ct-9227	12	42	causing	cause	VERB
ct-9227	12	43	the	the	DET
ct-9227	12	44	immune	immune	ADJ
ct-9227	12	45	privileged	privileged	ADJ
ct-9227	12	46	status	status	NOUN
ct-9227	12	47	of	of	ADP
ct-9227	12	48	allo	allo	NOUN
ct-9227	12	49	-	-	PUNCT
ct-9227	12	50	mscs	msc	NOUN
ct-9227	12	51	to	to	PART
ct-9227	12	52	be	be	AUX
ct-9227	12	53	questioned.4	questioned.4	PROPN
ct-9227	12	54	in	in	ADP
ct-9227	12	55	horse	horse	NOUN
ct-9227	12	56	,	,	PUNCT
ct-9227	12	57	published	publish	VERB
ct-9227	12	58	reports	report	NOUN
ct-9227	12	59	document	document	VERB
ct-9227	12	60	a	a	DET
ct-9227	12	61	regenerative	regenerative	ADJ
ct-9227	12	62	effect	effect	NOUN
ct-9227	12	63	when	when	SCONJ
ct-9227	12	64	autologous	autologous	ADJ
ct-9227	12	65	mscs	msc	NOUN
ct-9227	12	66	are	be	AUX
ct-9227	12	67	used	use	VERB
ct-9227	12	68	to	to	PART
ct-9227	12	69	treat	treat	VERB
ct-9227	12	70	joint	joint	ADJ
ct-9227	12	71	disease	disease	NOUN
ct-9227	12	72	,	,	PUNCT
ct-9227	12	73	but	but	CCONJ
ct-9227	12	74	anecdotal	anecdotal	ADJ
ct-9227	12	75	reports	report	NOUN
ct-9227	12	76	(	(	PUNCT
ct-9227	12	77	where	where	SCONJ
ct-9227	12	78	allogeneic	allogeneic	ADJ
ct-9227	12	79	mscs	msc	NOUN
ct-9227	12	80	are	be	AUX
ct-9227	12	81	often	often	ADV
ct-9227	12	82	used	use	VERB
ct-9227	12	83	)	)	PUNCT
ct-9227	12	84	are	be	AUX
ct-9227	12	85	of	of	ADP
ct-9227	12	86	minimal	minimal	ADJ
ct-9227	12	87	treatment	treatment	NOUN
ct-9227	12	88	effect	effect	NOUN
ct-9227	12	89	.	.	PUNCT
ct-9227	13	1	the	the	DET
ct-9227	13	2	lack	lack	NOUN
ct-9227	13	3	of	of	ADP
ct-9227	13	4	consistent	consistent	ADJ
ct-9227	13	5	lameness	lameness	NOUN
ct-9227	13	6	reduction	reduction	NOUN
ct-9227	13	7	is	be	AUX
ct-9227	13	8	because	because	SCONJ
ct-9227	13	9	allogeneic	allogeneic	ADJ
ct-9227	13	10	mscs	msc	NOUN
ct-9227	13	11	are	be	AUX
ct-9227	13	12	recognized	recognize	VERB
ct-9227	13	13	by	by	ADP
ct-9227	13	14	the	the	DET
ct-9227	13	15	immune	immune	ADJ
ct-9227	13	16	system	system	NOUN
ct-9227	13	17	,	,	PUNCT
ct-9227	13	18	thus	thus	ADV
ct-9227	13	19	precluding	preclude	VERB
ct-9227	13	20	the	the	DET
ct-9227	13	21	beneficial	beneficial	ADJ
ct-9227	13	22	effects	effect	NOUN
ct-9227	13	23	.	.	PUNCT
ct-9227	14	1	this	this	PRON
ct-9227	14	2	is	be	AUX
ct-9227	14	3	in	in	ADP
ct-9227	14	4	agreement	agreement	NOUN
ct-9227	14	5	with	with	ADP
ct-9227	14	6	our	our	PRON
ct-9227	14	7	previous	previous	ADJ
ct-9227	14	8	work	work	NOUN
ct-9227	14	9	that	that	PRON
ct-9227	14	10	showed	show	VERB
ct-9227	14	11	in	in	ADP
ct-9227	14	12	horse	horse	NOUN
ct-9227	14	13	a	a	DET
ct-9227	14	14	significant	significant	ADJ
ct-9227	14	15	adverse	adverse	ADJ
ct-9227	14	16	response	response	NOUN
ct-9227	14	17	when	when	SCONJ
ct-9227	14	18	allogenic	allogenic	NOUN
ct-9227	14	19	-	-	PUNCT
ct-9227	14	20	mscs	msc	NOUN
ct-9227	14	21	were	be	AUX
ct-9227	14	22	confined	confine	VERB
ct-9227	14	23	to	to	ADP
ct-9227	14	24	the	the	DET
ct-9227	14	25	intraarticular	intraarticular	ADJ
ct-9227	14	26	environment	environment	NOUN
ct-9227	14	27	compared	compare	VERB
ct-9227	14	28	to	to	ADP
ct-9227	14	29	auto	auto	NOUN
ct-9227	14	30	-	-	PUNCT
ct-9227	14	31	mscs.5	mscs.5	NOUN
ct-9227	14	32	long	long	ADV
ct-9227	14	33	considered	consider	VERB
ct-9227	14	34	immune	immune	ADJ
ct-9227	14	35	privileged	privileged	ADJ
ct-9227	14	36	,	,	PUNCT
ct-9227	14	37	allogeneic	allogeneic	ADJ
ct-9227	14	38	(	(	PUNCT
ct-9227	14	39	non	non	ADJ
ct-9227	14	40	-	-	NOUN
ct-9227	14	41	self	self	NOUN
ct-9227	14	42	,	,	PUNCT
ct-9227	14	43	from	from	ADP
ct-9227	14	44	one	one	NUM
ct-9227	14	45	horse	horse	NOUN
ct-9227	14	46	to	to	ADP
ct-9227	14	47	another	another	PRON
ct-9227	14	48	)	)	PUNCT
ct-9227	14	49	mesenchymal	mesenchymal	ADJ
ct-9227	14	50	stem	stem	NOUN
ct-9227	14	51	cells	cell	NOUN
ct-9227	14	52	(	(	PUNCT
ct-9227	14	53	mscs	msc	NOUN
ct-9227	14	54	)	)	PUNCT
ct-9227	14	55	have	have	AUX
ct-9227	14	56	enhanced	enhance	VERB
ct-9227	14	57	commercialization	commercialization	NOUN
ct-9227	14	58	potential.6,7	potential.6,7	SCONJ
ct-9227	14	59	the	the	DET
ct-9227	14	60	immune	immune	ADJ
ct-9227	14	61	privileged	privileged	ADJ
ct-9227	14	62	status	status	NOUN
ct-9227	14	63	of	of	ADP
ct-9227	14	64	mscs	msc	NOUN
ct-9227	14	65	stems	stem	VERB
ct-9227	14	66	from	from	ADP
ct-9227	14	67	absent	absent	ADJ
ct-9227	14	68	mhcii	mhcii	NOUN
ct-9227	14	69	expression	expression	NOUN
ct-9227	14	70	,	,	PUNCT
ct-9227	14	71	low	low	ADJ
ct-9227	14	72	mhci	mhci	NOUN
ct-9227	14	73	expression	expression	NOUN
ct-9227	14	74	,	,	PUNCT
ct-9227	14	75	and	and	CCONJ
ct-9227	14	76	immunomodulatory	immunomodulatory	ADJ
ct-9227	14	77	action	action	NOUN
ct-9227	14	78	by	by	ADP
ct-9227	14	79	mscs	msc	NOUN
ct-9227	14	80	.	.	PUNCT
ct-9227	15	1	despite	despite	SCONJ
ct-9227	15	2	low	low	ADJ
ct-9227	15	3	expression	expression	NOUN
ct-9227	15	4	of	of	ADP
ct-9227	15	5	mhci	mhci	NOUN
ct-9227	15	6	,	,	PUNCT
ct-9227	15	7	we	we	PRON
ct-9227	15	8	have	have	AUX
ct-9227	15	9	recently	recently	ADV
ct-9227	15	10	demonstrated	demonstrate	VERB
ct-9227	15	11	immune	immune	ADJ
ct-9227	15	12	recognition	recognition	NOUN
ct-9227	15	13	of	of	ADP
ct-9227	15	14	non	non	ADJ
ct-9227	15	15	-	-	ADJ
ct-9227	15	16	self	self	ADJ
ct-9227	15	17	mscs	msc	NOUN
ct-9227	15	18	in	in	ADP
ct-9227	15	19	horses	horse	NOUN
ct-9227	15	20	.	.	PUNCT
ct-9227	16	1	this	this	DET
ct-9227	16	2	immune	immune	ADJ
ct-9227	16	3	recognition	recognition	NOUN
ct-9227	16	4	may	may	AUX
ct-9227	16	5	explain	explain	VERB
ct-9227	16	6	the	the	DET
ct-9227	16	7	greater	great	ADJ
ct-9227	16	8	variability	variability	NOUN
ct-9227	16	9	in	in	ADP
ct-9227	16	10	efficacy	efficacy	NOUN
ct-9227	16	11	of	of	ADP
ct-9227	16	12	allogeneic	allogeneic	ADJ
ct-9227	16	13	therapies	therapy	NOUN
ct-9227	16	14	that	that	PRON
ct-9227	16	15	has	have	AUX
ct-9227	16	16	been	be	AUX
ct-9227	16	17	recognized	recognize	VERB
ct-9227	16	18	in	in	ADP
ct-9227	16	19	people	people	NOUN
ct-9227	16	20	and	and	CCONJ
ct-9227	16	21	suggested	suggest	VERB
ct-9227	16	22	in	in	ADP
ct-9227	16	23	the	the	DET
ct-9227	16	24	horse.3,4,8,9	horse.3,4,8,9	NOUN
ct-9227	16	25	our	our	PRON
ct-9227	16	26	recent	recent	ADJ
ct-9227	16	27	work	work	NOUN
ct-9227	16	28	,	,	PUNCT
ct-9227	16	29	along	along	ADP
ct-9227	16	30	with	with	ADP
ct-9227	16	31	data	datum	NOUN
ct-9227	16	32	from	from	ADP
ct-9227	16	33	equine	equine	NOUN
ct-9227	16	34	researchers	researcher	NOUN
ct-9227	16	35	at	at	ADP
ct-9227	16	36	ncsu	ncsu	PROPN
ct-9227	16	37	demonstrating	demonstrate	VERB
ct-9227	16	38	cytotoxic	cytotoxic	ADJ
ct-9227	16	39	t	t	NOUN
ct-9227	16	40	cell	cell	NOUN
ct-9227	16	41	responses	response	NOUN
ct-9227	16	42	in	in	ADP
ct-9227	16	43	vitro	vitro	ADJ
ct-9227	16	44	after	after	ADP
ct-9227	16	45	allogeneic	allogeneic	ADJ
ct-9227	16	46	msc	msc	PROPN
ct-9227	16	47	administration	administration	PROPN
ct-9227	16	48	,	,	PUNCT
ct-9227	16	49	provides	provide	VERB
ct-9227	16	50	sufficient	sufficient	ADJ
ct-9227	16	51	evidence	evidence	NOUN
ct-9227	16	52	to	to	PART
ct-9227	16	53	question	question	VERB
ct-9227	16	54	not	not	PART
ct-9227	16	55	only	only	ADV
ct-9227	16	56	the	the	DET
ct-9227	16	57	efficacy	efficacy	NOUN
ct-9227	16	58	but	but	CCONJ
ct-9227	16	59	also	also	ADV
ct-9227	16	60	the	the	DET
ct-9227	16	61	safety	safety	NOUN
ct-9227	16	62	of	of	ADP
ct-9227	16	63	allogeneic	allogeneic	ADJ
ct-9227	16	64	mscs	msc	NOUN
ct-9227	16	65	in	in	ADP
ct-9227	16	66	the	the	DET
ct-9227	16	67	horse.10,11	horse.10,11	NOUN
ct-9227	16	68	despite	despite	SCONJ
ct-9227	16	69	decades	decade	NOUN
ct-9227	16	70	of	of	ADP
ct-9227	16	71	mesenchymal	mesenchymal	ADJ
ct-9227	16	72	stromal	stromal	ADJ
ct-9227	16	73	cell	cell	NOUN
ct-9227	16	74	(	(	PUNCT
ct-9227	16	75	msc	msc	NOUN
ct-9227	16	76	)	)	PUNCT
ct-9227	16	77	therapy	therapy	NOUN
ct-9227	16	78	,	,	PUNCT
ct-9227	16	79	definitive	definitive	ADJ
ct-9227	16	80	clinical	clinical	ADJ
ct-9227	16	81	evidence	evidence	NOUN
ct-9227	16	82	of	of	ADP
ct-9227	16	83	efficacy	efficacy	NOUN
ct-9227	16	84	does	do	AUX
ct-9227	16	85	not	not	PART
ct-9227	16	86	exist	exist	VERB
ct-9227	16	87	,	,	PUNCT
ct-9227	16	88	and	and	CCONJ
ct-9227	16	89	it	it	PRON
ct-9227	16	90	has	have	AUX
ct-9227	16	91	been	be	AUX
ct-9227	16	92	postulated	postulate	VERB
ct-9227	16	93	that	that	SCONJ
ct-9227	16	94	lack	lack	NOUN
ct-9227	16	95	of	of	ADP
ct-9227	16	96	efficacy	efficacy	NOUN
ct-9227	16	97	is	be	AUX
ct-9227	16	98	due	due	ADJ
ct-9227	16	99	to	to	ADP
ct-9227	16	100	msc	msc	PROPN
ct-9227	16	101	preparation	preparation	NOUN
ct-9227	16	102	technique.12,13	technique.12,13	NOUN
ct-9227	16	103	supplementation	supplementation	NOUN
ct-9227	16	104	of	of	ADP
ct-9227	16	105	mesenchymal	mesenchymal	ADJ
ct-9227	16	106	stromal	stromal	ADJ
ct-9227	16	107	cells	cell	NOUN
ct-9227	16	108	(	(	PUNCT
ct-9227	16	109	mscs	msc	NOUN
ct-9227	16	110	)	)	PUNCT
ct-9227	16	111	with	with	ADP
ct-9227	16	112	fetal	fetal	ADJ
ct-9227	16	113	bovine	bovine	NOUN
ct-9227	16	114	serum	serum	NOUN
ct-9227	16	115	(	(	PUNCT
ct-9227	16	116	fbs	fbs	PROPN
ct-9227	16	117	)	)	PUNCT
ct-9227	16	118	has	have	AUX
ct-9227	16	119	been	be	AUX
ct-9227	16	120	a	a	DET
ct-9227	16	121	standard	standard	ADJ
ct-9227	16	122	practice	practice	NOUN
ct-9227	16	123	since	since	SCONJ
ct-9227	16	124	mscs	msc	NOUN
ct-9227	16	125	were	be	AUX
ct-9227	16	126	first	first	ADV
ct-9227	16	127	described	describe	VERB
ct-9227	16	128	in	in	ADP
ct-9227	16	129	1970.14	1970.14	NUM
ct-9227	16	130	since	since	SCONJ
ct-9227	16	131	then	then	ADV
ct-9227	16	132	,	,	PUNCT
ct-9227	16	133	numerous	numerous	ADJ
ct-9227	16	134	veterinary	veterinary	ADJ
ct-9227	16	135	and	and	CCONJ
ct-9227	16	136	human	human	ADJ
ct-9227	16	137	medical	medical	ADJ
ct-9227	16	138	patients	patient	NOUN
ct-9227	16	139	have	have	AUX
ct-9227	16	140	received	receive	VERB
ct-9227	16	141	mscs	msc	NOUN
ct-9227	16	142	supplemented	supplement	VERB
ct-9227	16	143	with	with	ADP
ct-9227	16	144	fbs	fbs	PROPN
ct-9227	16	145	for	for	ADP
ct-9227	16	146	various	various	ADJ
ct-9227	16	147	medical	medical	ADJ
ct-9227	16	148	conditions	condition	NOUN
ct-9227	16	149	,	,	PUNCT
ct-9227	16	150	clinical	clinical	ADJ
ct-9227	16	151	theriogenology	theriogenology	NOUN
ct-9227	16	152	•	•	NOUN
ct-9227	16	153	volume	volume	NOUN
ct-9227	16	154	12	12	NUM
ct-9227	16	155	number	number	NOUN
ct-9227	16	156	3	3	NUM
ct-9227	16	157	•	•	NOUN
ct-9227	16	158	september	september	PROPN
ct-9227	16	159	2020180	2020180	NUM
ct-9227	16	160	including	include	VERB
ct-9227	16	161	osteoarthritis	osteoarthritis	NOUN
ct-9227	16	162	.	.	PUNCT
ct-9227	17	1	although	although	SCONJ
ct-9227	17	2	clinical	clinical	ADJ
ct-9227	17	3	detection	detection	NOUN
ct-9227	17	4	of	of	ADP
ct-9227	17	5	adverse	adverse	ADJ
ct-9227	17	6	reactions	reaction	NOUN
ct-9227	17	7	appears	appear	VERB
ct-9227	17	8	to	to	PART
ct-9227	17	9	be	be	AUX
ct-9227	17	10	rare	rare	ADJ
ct-9227	17	11	,	,	PUNCT
ct-9227	17	12	xenogen	xenogen	PROPN
ct-9227	17	13	exposure	exposure	NOUN
ct-9227	17	14	to	to	ADP
ct-9227	17	15	the	the	DET
ct-9227	17	16	msc	msc	PROPN
ct-9227	17	17	recipient	recipient	NOUN
ct-9227	17	18	because	because	SCONJ
ct-9227	17	19	of	of	ADP
ct-9227	17	20	fbs	fbs	ADJ
ct-9227	17	21	supplementation	supplementation	NOUN
ct-9227	17	22	can	can	AUX
ct-9227	17	23	cause	cause	VERB
ct-9227	17	24	local	local	ADJ
ct-9227	17	25	reactions,15	reactions,15	NOUN
ct-9227	17	26	anaphlyaxis,16	anaphlyaxis,16	NOUN
ct-9227	17	27	and	and	CCONJ
ct-9227	17	28	anamnestic	anamnestic	ADJ
ct-9227	17	29	responses,17	responses,17	NOUN
ct-9227	17	30	which	which	PRON
ct-9227	17	31	have	have	AUX
ct-9227	17	32	been	be	AUX
ct-9227	17	33	associated	associate	VERB
ct-9227	17	34	with	with	ADP
ct-9227	17	35	msc	msc	PROPN
ct-9227	17	36	-	-	PUNCT
ct-9227	17	37	non	non	NOUN
ct-9227	17	38	response.18	response.18	NOUN
ct-9227	17	39	while	while	SCONJ
ct-9227	17	40	immune	immune	ADJ
ct-9227	17	41	recognition	recognition	NOUN
ct-9227	17	42	and	and	CCONJ
ct-9227	17	43	resultant	resultant	VERB
ct-9227	17	44	adverse	adverse	ADJ
ct-9227	17	45	reactions	reaction	NOUN
ct-9227	17	46	are	be	AUX
ct-9227	17	47	concerning	concern	VERB
ct-9227	17	48	,	,	PUNCT
ct-9227	17	49	immune	immune	ADJ
ct-9227	17	50	recognition	recognition	NOUN
ct-9227	17	51	and	and	CCONJ
ct-9227	17	52	resultant	resultant	VERB
ct-9227	17	53	cytotoxicity	cytotoxicity	NOUN
ct-9227	17	54	against	against	ADP
ct-9227	17	55	mscs	msc	NOUN
ct-9227	17	56	may	may	AUX
ct-9227	17	57	be	be	AUX
ct-9227	17	58	a	a	DET
ct-9227	17	59	key	key	ADJ
ct-9227	17	60	factor	factor	NOUN
ct-9227	17	61	in	in	ADP
ct-9227	17	62	the	the	DET
ct-9227	17	63	elusive	elusive	ADJ
ct-9227	17	64	proof	proof	NOUN
ct-9227	17	65	of	of	ADP
ct-9227	17	66	msc	msc	PROPN
ct-9227	17	67	efficacy	efficacy	NOUN
ct-9227	17	68	for	for	ADP
ct-9227	17	69	most	most	ADJ
ct-9227	17	70	applications	application	NOUN
ct-9227	17	71	including	include	VERB
ct-9227	17	72	osteoarthritis.13,19	osteoarthritis.13,19	VERB
ct-9227	17	73	many	many	ADJ
ct-9227	17	74	blood	blood	NOUN
ct-9227	17	75	derivatives	derivative	NOUN
ct-9227	17	76	including	include	VERB
ct-9227	17	77	platelet	platelet	NOUN
ct-9227	17	78	products,20	products,20	ADJ
ct-9227	17	79	umbilical	umbilical	ADJ
ct-9227	17	80	cord	cord	NOUN
ct-9227	17	81	blood	blood	NOUN
ct-9227	17	82	serum21	serum21	NOUN
ct-9227	17	83	and	and	CCONJ
ct-9227	17	84	chemically	chemically	ADV
ct-9227	17	85	defined	define	VERB
ct-9227	17	86	media	medium	NOUN
ct-9227	17	87	have	have	AUX
ct-9227	17	88	been	be	AUX
ct-9227	17	89	investigated	investigate	VERB
ct-9227	17	90	to	to	PART
ct-9227	17	91	replace	replace	VERB
ct-9227	17	92	fbs	fbs	ADJ
ct-9227	17	93	supplementation	supplementation	NOUN
ct-9227	17	94	of	of	ADP
ct-9227	17	95	mscs	msc	NOUN
ct-9227	17	96	.	.	PUNCT
ct-9227	18	1	based	base	VERB
ct-9227	18	2	on	on	ADP
ct-9227	18	3	the	the	DET
ct-9227	18	4	ever	ever	ADV
ct-9227	18	5	-	-	PUNCT
ct-9227	18	6	decreasing	decrease	VERB
ct-9227	18	7	proportion	proportion	NOUN
ct-9227	18	8	of	of	ADP
ct-9227	18	9	clinical.trials.gov	clinical.trials.gov	PROPN
ct-9227	18	10	registered	register	VERB
ct-9227	18	11	msc	msc	PROPN
ct-9227	18	12	trials	trial	NOUN
ct-9227	18	13	,	,	PUNCT
ct-9227	18	14	with	with	ADP
ct-9227	18	15	fbs	fbs	ADJ
ct-9227	18	16	supplementation	supplementation	NOUN
ct-9227	18	17	of	of	ADP
ct-9227	18	18	80	80	NUM
ct-9227	18	19	%	%	NOUN
ct-9227	18	20	of	of	ADP
ct-9227	18	21	regulatory	regulatory	ADJ
ct-9227	18	22	submissions	submission	NOUN
ct-9227	18	23	in	in	ADP
ct-9227	18	24	20141	20141	NUM
ct-9227	18	25	to	to	ADP
ct-9227	18	26	40	40	NUM
ct-9227	18	27	%	%	NOUN
ct-9227	18	28	in	in	ADP
ct-9227	18	29	2019	2019	NUM
ct-9227	18	30	,	,	PUNCT
ct-9227	18	31	it	it	PRON
ct-9227	18	32	appears	appear	VERB
ct-9227	18	33	that	that	SCONJ
ct-9227	18	34	the	the	DET
ct-9227	18	35	human	human	ADJ
ct-9227	18	36	regenerative	regenerative	ADJ
ct-9227	18	37	medicine	medicine	NOUN
ct-9227	18	38	field	field	NOUN
ct-9227	18	39	agrees	agree	VERB
ct-9227	18	40	that	that	SCONJ
ct-9227	18	41	fbs	fbs	PROPN
ct-9227	18	42	should	should	AUX
ct-9227	18	43	be	be	AUX
ct-9227	18	44	replaced	replace	VERB
ct-9227	18	45	.	.	PUNCT
ct-9227	19	1	surprisingly	surprisingly	ADV
ct-9227	19	2	,	,	PUNCT
ct-9227	19	3	the	the	DET
ct-9227	19	4	veterinary	veterinary	ADJ
ct-9227	19	5	regenerative	regenerative	ADJ
ct-9227	19	6	medicine	medicine	NOUN
ct-9227	19	7	community	community	NOUN
ct-9227	19	8	has	have	AUX
ct-9227	19	9	not	not	PART
ct-9227	19	10	adopted	adopt	VERB
ct-9227	19	11	this	this	DET
ct-9227	19	12	stance	stance	NOUN
ct-9227	19	13	and	and	CCONJ
ct-9227	19	14	fbs	fbs	ADJ
ct-9227	19	15	supplementation	supplementation	NOUN
ct-9227	19	16	of	of	ADP
ct-9227	19	17	mscs	msc	NOUN
ct-9227	19	18	remains	remain	VERB
ct-9227	19	19	the	the	DET
ct-9227	19	20	industry	industry	NOUN
ct-9227	19	21	standard.2,3	standard.2,3	NOUN
ct-9227	19	22	similarly	similarly	ADV
ct-9227	19	23	,	,	PUNCT
ct-9227	19	24	fbs	fbs	PROPN
ct-9227	19	25	supplementation	supplementation	NOUN
ct-9227	19	26	remains	remain	VERB
ct-9227	19	27	well	well	ADV
ct-9227	19	28	-	-	PUNCT
ct-9227	19	29	accepted	accept	VERB
ct-9227	19	30	in	in	ADP
ct-9227	19	31	many	many	ADJ
ct-9227	19	32	preclinical	preclinical	ADJ
ct-9227	19	33	msc	msc	NOUN
ct-9227	19	34	investigations	investigation	NOUN
ct-9227	19	35	in	in	ADP
ct-9227	19	36	laboratory	laboratory	NOUN
ct-9227	19	37	animals.22	animals.22	NOUN
ct-9227	19	38	this	this	PRON
ct-9227	19	39	may	may	AUX
ct-9227	19	40	be	be	AUX
ct-9227	19	41	because	because	SCONJ
ct-9227	19	42	definitive	definitive	ADJ
ct-9227	19	43	evidence	evidence	NOUN
ct-9227	19	44	for	for	ADP
ct-9227	19	45	immune	immune	ADJ
ct-9227	19	46	targeting	targeting	NOUN
ct-9227	19	47	and	and	CCONJ
ct-9227	19	48	cytotoxicity	cytotoxicity	NOUN
ct-9227	19	49	of	of	ADP
ct-9227	19	50	fbs	fbs	PROPN
ct-9227	19	51	supplemented	supplement	VERB
ct-9227	19	52	mscs	msc	NOUN
ct-9227	19	53	does	do	AUX
ct-9227	19	54	not	not	PART
ct-9227	19	55	exist	exist	VERB
ct-9227	19	56	.	.	PUNCT
ct-9227	20	1	regardless	regardless	ADV
ct-9227	20	2	of	of	ADP
ct-9227	20	3	this	this	DET
ct-9227	20	4	disparity	disparity	NOUN
ct-9227	20	5	in	in	ADP
ct-9227	20	6	human	human	ADJ
ct-9227	20	7	,	,	PUNCT
ct-9227	20	8	veterinary	veterinary	ADJ
ct-9227	20	9	and	and	CCONJ
ct-9227	20	10	preclinical	preclinical	ADJ
ct-9227	20	11	fields	field	NOUN
ct-9227	20	12	,	,	PUNCT
ct-9227	20	13	it	it	PRON
ct-9227	20	14	appears	appear	VERB
ct-9227	20	15	that	that	SCONJ
ct-9227	20	16	no	no	DET
ct-9227	20	17	autologous	autologous	ADJ
ct-9227	20	18	supplement	supplement	NOUN
ct-9227	20	19	has	have	AUX
ct-9227	20	20	replaced	replace	VERB
ct-9227	20	21	fbs	fb	VERB
ct-9227	20	22	with	with	ADP
ct-9227	20	23	unaltered	unaltered	ADJ
ct-9227	20	24	growth	growth	NOUN
ct-9227	20	25	,	,	PUNCT
ct-9227	20	26	characterization	characterization	NOUN
ct-9227	20	27	or	or	CCONJ
ct-9227	20	28	clinical	clinical	ADJ
ct-9227	20	29	efficacy	efficacy	NOUN
ct-9227	20	30	of	of	ADP
ct-9227	20	31	mscs	msc	NOUN
ct-9227	20	32	.	.	PUNCT
ct-9227	21	1	we	we	PRON
ct-9227	21	2	have	have	AUX
ct-9227	21	3	previously	previously	ADV
ct-9227	21	4	shown	show	VERB
ct-9227	21	5	that	that	SCONJ
ct-9227	21	6	48	48	NUM
ct-9227	21	7	hours	hour	NOUN
ct-9227	21	8	of	of	ADP
ct-9227	21	9	fbs	fbs	ADJ
ct-9227	21	10	depletion	depletion	NOUN
ct-9227	21	11	is	be	AUX
ct-9227	21	12	sufficient	sufficient	ADJ
ct-9227	21	13	to	to	PART
ct-9227	21	14	mitigate	mitigate	VERB
ct-9227	21	15	the	the	DET
ct-9227	21	16	mild	mild	ADJ
ct-9227	21	17	local	local	ADJ
ct-9227	21	18	adverse	adverse	ADJ
ct-9227	21	19	reaction	reaction	NOUN
ct-9227	21	20	after	after	ADP
ct-9227	21	21	repeated	repeat	VERB
ct-9227	21	22	intra	intra	ADJ
ct-9227	21	23	-	-	ADJ
ct-9227	21	24	articular	articular	ADJ
ct-9227	21	25	injection	injection	NOUN
ct-9227	21	26	of	of	ADP
ct-9227	21	27	mscs	msc	NOUN
ct-9227	21	28	supplemented	supplement	VERB
ct-9227	21	29	with	with	ADP
ct-9227	21	30	fbs	fbs	PROPN
ct-9227	21	31	in	in	ADP
ct-9227	21	32	horses.5	horses.5	PROPN
ct-9227	21	33	we	we	PRON
ct-9227	21	34	sought	seek	VERB
ct-9227	21	35	to	to	PART
ct-9227	21	36	develop	develop	VERB
ct-9227	21	37	an	an	DET
ct-9227	21	38	autologous	autologous	ADJ
ct-9227	21	39	,	,	PUNCT
ct-9227	21	40	xenogen	xenogen	NOUN
ct-9227	21	41	-	-	PUNCT
ct-9227	21	42	free	free	ADJ
ct-9227	21	43	method	method	NOUN
ct-9227	21	44	for	for	ADP
ct-9227	21	45	supplementation	supplementation	NOUN
ct-9227	21	46	of	of	ADP
ct-9227	21	47	mscs	msc	NOUN
ct-9227	21	48	that	that	PRON
ct-9227	21	49	would	would	AUX
ct-9227	21	50	obviate	obviate	VERB
ct-9227	21	51	immune	immune	ADJ
ct-9227	21	52	targeting	targeting	NOUN
ct-9227	21	53	of	of	ADP
ct-9227	21	54	transplanted	transplant	VERB
ct-9227	21	55	mscs	msc	NOUN
ct-9227	21	56	by	by	ADP
ct-9227	21	57	the	the	DET
ct-9227	21	58	recipient	recipient	NOUN
ct-9227	21	59	,	,	PUNCT
ct-9227	21	60	by	by	ADP
ct-9227	21	61	removing	remove	VERB
ct-9227	21	62	fbs	fb	NOUN
ct-9227	21	63	for	for	ADP
ct-9227	21	64	the	the	DET
ct-9227	21	65	entire	entire	ADJ
ct-9227	21	66	culture	culture	NOUN
ct-9227	21	67	period	period	NOUN
ct-9227	21	68	.	.	PUNCT
ct-9227	22	1	our	our	PRON
ct-9227	22	2	efforts	effort	NOUN
ct-9227	22	3	with	with	ADP
ct-9227	22	4	platelet	platelet	NOUN
ct-9227	22	5	lysate	lysate	NOUN
ct-9227	22	6	and	and	CCONJ
ct-9227	22	7	platelet	platelet	NOUN
ct-9227	22	8	releasate	releasate	NOUN
ct-9227	22	9	,	,	PUNCT
ct-9227	22	10	both	both	CCONJ
ct-9227	22	11	autologous	autologous	ADJ
ct-9227	22	12	and	and	CCONJ
ct-9227	22	13	pooled	pool	VERB
ct-9227	22	14	,	,	PUNCT
ct-9227	22	15	were	be	AUX
ct-9227	22	16	disappointing	disappointing	ADJ
ct-9227	22	17	as	as	SCONJ
ct-9227	22	18	has	have	AUX
ct-9227	22	19	been	be	AUX
ct-9227	22	20	previously	previously	ADV
ct-9227	22	21	reported.23	reported.23	VERB
ct-9227	22	22	with	with	ADP
ct-9227	22	23	platelet	platelet	NOUN
ct-9227	22	24	products	product	NOUN
ct-9227	22	25	,	,	PUNCT
ct-9227	22	26	isolation	isolation	NOUN
ct-9227	22	27	of	of	ADP
ct-9227	22	28	mscs	msc	NOUN
ct-9227	22	29	was	be	AUX
ct-9227	22	30	generally	generally	ADV
ct-9227	22	31	successful	successful	ADJ
ct-9227	22	32	,	,	PUNCT
ct-9227	22	33	but	but	CCONJ
ct-9227	22	34	growth	growth	NOUN
ct-9227	22	35	kinetics	kinetic	NOUN
ct-9227	22	36	,	,	PUNCT
ct-9227	22	37	cell	cell	NOUN
ct-9227	22	38	surface	surface	NOUN
ct-9227	22	39	markers	marker	NOUN
ct-9227	22	40	,	,	PUNCT
ct-9227	22	41	cell	cell	NOUN
ct-9227	22	42	morphology	morphology	NOUN
ct-9227	22	43	and	and	CCONJ
ct-9227	22	44	differentiation	differentiation	NOUN
ct-9227	22	45	ability	ability	NOUN
ct-9227	22	46	were	be	AUX
ct-9227	22	47	more	more	ADV
ct-9227	22	48	variable	variable	ADJ
ct-9227	22	49	when	when	SCONJ
ct-9227	22	50	compared	compare	VERB
ct-9227	22	51	to	to	ADP
ct-9227	22	52	the	the	DET
ct-9227	22	53	response	response	NOUN
ct-9227	22	54	to	to	ADP
ct-9227	22	55	fbs	fbs	ADJ
ct-9227	22	56	supplementation	supplementation	NOUN
ct-9227	22	57	by	by	ADP
ct-9227	22	58	the	the	DET
ct-9227	22	59	same	same	ADJ
ct-9227	22	60	donors	donor	NOUN
ct-9227	22	61	.	.	PUNCT
ct-9227	23	1	by	by	ADP
ct-9227	23	2	developing	develop	VERB
ct-9227	23	3	a	a	DET
ct-9227	23	4	replacement	replacement	NOUN
ct-9227	23	5	to	to	PART
ct-9227	23	6	fetal	fetal	VERB
ct-9227	23	7	bovine	bovine	NOUN
ct-9227	23	8	serum	serum	NOUN
ct-9227	23	9	supplementation	supplementation	NOUN
ct-9227	23	10	of	of	ADP
ct-9227	23	11	msc	msc	PROPN
ct-9227	23	12	culture	culture	PROPN
ct-9227	23	13	,	,	PUNCT
ct-9227	23	14	immune	immune	ADJ
ct-9227	23	15	mediated	mediate	VERB
ct-9227	23	16	targeting	targeting	NOUN
ct-9227	23	17	of	of	ADP
ct-9227	23	18	culture	culture	NOUN
ct-9227	23	19	expanded	expand	VERB
ct-9227	23	20	cells	cell	NOUN
ct-9227	23	21	will	will	AUX
ct-9227	23	22	be	be	AUX
ct-9227	23	23	abolished	abolish	VERB
ct-9227	23	24	.	.	PUNCT
ct-9227	24	1	by	by	ADP
ct-9227	24	2	evaluating	evaluate	VERB
ct-9227	24	3	immune	immune	ADJ
ct-9227	24	4	reaction	reaction	NOUN
ct-9227	24	5	of	of	ADP
ct-9227	24	6	matched	match	VERB
ct-9227	24	7	and	and	CCONJ
ct-9227	24	8	mismatched	mismatched	ADJ
ct-9227	24	9	recipients	recipient	NOUN
ct-9227	24	10	we	we	PRON
ct-9227	24	11	are	be	AUX
ct-9227	24	12	developing	develop	VERB
ct-9227	24	13	a	a	DET
ct-9227	24	14	hierarchy	hierarchy	NOUN
ct-9227	24	15	of	of	ADP
ct-9227	24	16	stem	stem	NOUN
ct-9227	24	17	cell	cell	NOUN
ct-9227	24	18	immunogenicity	immunogenicity	NOUN
ct-9227	24	19	,	,	PUNCT
ct-9227	24	20	which	which	PRON
ct-9227	24	21	is	be	AUX
ct-9227	24	22	a	a	DET
ct-9227	24	23	necessary	necessary	ADJ
ct-9227	24	24	step	step	NOUN
ct-9227	24	25	in	in	ADP
ct-9227	24	26	pursuit	pursuit	NOUN
ct-9227	24	27	of	of	ADP
ct-9227	24	28	an	an	DET
ct-9227	24	29	acceptable	acceptable	ADJ
ct-9227	24	30	allogeneic	allogeneic	ADJ
ct-9227	24	31	donor	donor	NOUN
ct-9227	24	32	.	.	PUNCT
ct-9227	25	1	conflict	conflict	NOUN
ct-9227	25	2	of	of	ADP
ct-9227	25	3	interest	interest	NOUN
ct-9227	25	4	:	:	PUNCT
ct-9227	25	5	none	none	NOUN
ct-9227	25	6	to	to	PART
ct-9227	25	7	report	report	VERB
ct-9227	25	8	.	.	PUNCT
ct-9227	26	1	references	reference	NOUN
ct-9227	26	2	1	1	NUM
ct-9227	26	3	.	.	PUNCT
ct-9227	26	4	mendicino	mendicino	PROPN
ct-9227	26	5	m	m	PROPN
ct-9227	26	6	,	,	PUNCT
ct-9227	26	7	bailey	bailey	PROPN
ct-9227	26	8	am	be	AUX
ct-9227	26	9	,	,	PUNCT
ct-9227	26	10	wonnacott	wonnacott	PROPN
ct-9227	26	11	k	k	NOUN
ct-9227	26	12	:	:	PUNCT
ct-9227	26	13	msc	msc	NOUN
ct-9227	26	14	-	-	PUNCT
ct-9227	26	15	based	base	VERB
ct-9227	26	16	product	product	NOUN
ct-9227	26	17	characterization	characterization	NOUN
ct-9227	26	18	for	for	ADP
ct-9227	26	19	clinical	clinical	ADJ
ct-9227	26	20	trials	trial	NOUN
ct-9227	26	21	:	:	PUNCT
ct-9227	26	22	an	an	DET
ct-9227	26	23	fda	fda	PROPN
ct-9227	26	24	perspective	perspective	NOUN
ct-9227	26	25	.	.	PUNCT
ct-9227	27	1	cell	cell	NOUN
ct-9227	27	2	stem	stem	NOUN
ct-9227	27	3	cell	cell	NOUN
ct-9227	27	4	2014;14:141	2014;14:141	NOUN
ct-9227	27	5	-	-	SYM
ct-9227	27	6	145	145	NUM
ct-9227	27	7	.	.	PUNCT
ct-9227	28	1	2	2	NUM
ct-9227	28	2	.	.	X
ct-9227	28	3	colbath	colbath	PROPN
ct-9227	28	4	ac	ac	PROPN
ct-9227	28	5	,	,	PUNCT
ct-9227	28	6	dow	dow	PROPN
ct-9227	28	7	sw	sw	PROPN
ct-9227	28	8	,	,	PUNCT
ct-9227	28	9	hopkins	hopkins	PROPN
ct-9227	28	10	ls	ls	PROPN
ct-9227	28	11	,	,	PUNCT
ct-9227	28	12	et	et	PROPN
ct-9227	28	13	al	al	PROPN
ct-9227	28	14	:	:	PUNCT
ct-9227	28	15	allogeneic	allogeneic	VERB
ct-9227	28	16	vs.	vs.	ADP
ct-9227	28	17	autologous	autologous	ADJ
ct-9227	28	18	intra	intra	ADJ
ct-9227	28	19	-	-	ADJ
ct-9227	28	20	articular	articular	ADJ
ct-9227	28	21	mesenchymal	mesenchymal	ADJ
ct-9227	28	22	stem	stem	NOUN
ct-9227	28	23	cell	cell	NOUN
ct-9227	28	24	injection	injection	NOUN
ct-9227	28	25	within	within	ADP
ct-9227	28	26	normal	normal	ADJ
ct-9227	28	27	horses	horse	NOUN
ct-9227	28	28	:	:	PUNCT
ct-9227	28	29	clinical	clinical	ADJ
ct-9227	28	30	and	and	CCONJ
ct-9227	28	31	cytological	cytological	ADJ
ct-9227	28	32	comparisons	comparison	NOUN
ct-9227	28	33	suggest	suggest	VERB
ct-9227	28	34	safety	safety	NOUN
ct-9227	28	35	.	.	PUNCT
ct-9227	29	1	equine	equine	NOUN
ct-9227	29	2	vet	vet	NOUN
ct-9227	29	3	j	j	PROPN
ct-9227	29	4	2019	2019	NUM
ct-9227	29	5	may	may	PROPN
ct-9227	29	6	23	23	NUM
ct-9227	29	7	,	,	PUNCT
ct-9227	29	8	3	3	NUM
ct-9227	29	9	.	.	NOUN
ct-9227	29	10	owens	owens	PROPN
ct-9227	29	11	sd	sd	PROPN
ct-9227	29	12	,	,	PUNCT
ct-9227	29	13	kol	kol	PROPN
ct-9227	29	14	a	a	PROPN
ct-9227	29	15	,	,	PUNCT
ct-9227	29	16	walker	walker	PROPN
ct-9227	29	17	nj	nj	PROPN
ct-9227	29	18	,	,	PUNCT
ct-9227	29	19	et	et	PROPN
ct-9227	29	20	al	al	PROPN
ct-9227	29	21	:	:	PUNCT
ct-9227	29	22	allogeneic	allogeneic	ADJ
ct-9227	29	23	mesenchymal	mesenchymal	NOUN
ct-9227	29	24	stem	stem	NOUN
ct-9227	29	25	cell	cell	NOUN
ct-9227	29	26	treatment	treatment	NOUN
ct-9227	29	27	induces	induce	VERB
ct-9227	29	28	specific	specific	ADJ
ct-9227	29	29	alloantibodies	alloantibody	NOUN
ct-9227	29	30	in	in	ADP
ct-9227	29	31	horses	horse	NOUN
ct-9227	29	32	.	.	PUNCT
ct-9227	30	1	stem	stem	NOUN
ct-9227	30	2	cells	cell	NOUN
ct-9227	30	3	int	int	NOUN
ct-9227	30	4	2016;2016:5830103	2016;2016:5830103	NUM
ct-9227	30	5	.	.	PROPN
ct-9227	30	6	4	4	NUM
ct-9227	30	7	.	.	X
ct-9227	30	8	nauta	nauta	PROPN
ct-9227	30	9	aj	aj	PROPN
ct-9227	30	10	,	,	PUNCT
ct-9227	30	11	westerhuis	westerhuis	PROPN
ct-9227	30	12	g	g	PROPN
ct-9227	30	13	,	,	PUNCT
ct-9227	30	14	kruisselbrink	kruisselbrink	PROPN
ct-9227	30	15	ab	ab	PROPN
ct-9227	30	16	,	,	PUNCT
ct-9227	30	17	et	et	PROPN
ct-9227	30	18	al	al	PROPN
ct-9227	30	19	:	:	PUNCT
ct-9227	30	20	donor	donor	NOUN
ct-9227	30	21	-	-	PUNCT
ct-9227	30	22	derived	derive	VERB
ct-9227	30	23	mesenchymal	mesenchymal	NOUN
ct-9227	30	24	stem	stem	NOUN
ct-9227	30	25	cells	cell	NOUN
ct-9227	30	26	are	be	AUX
ct-9227	30	27	immunogenic	immunogenic	ADJ
ct-9227	30	28	in	in	ADP
ct-9227	30	29	an	an	DET
ct-9227	30	30	allogeneic	allogeneic	ADJ
ct-9227	30	31	host	host	NOUN
ct-9227	30	32	and	and	CCONJ
ct-9227	30	33	stimulate	stimulate	VERB
ct-9227	30	34	donor	donor	NOUN
ct-9227	30	35	graft	graft	NOUN
ct-9227	30	36	rejection	rejection	NOUN
ct-9227	30	37	in	in	ADP
ct-9227	30	38	a	a	DET
ct-9227	30	39	nonmyeloablative	nonmyeloablative	ADJ
ct-9227	30	40	setting	setting	NOUN
ct-9227	30	41	.	.	PUNCT
ct-9227	31	1	blood	blood	NOUN
ct-9227	31	2	2006;108:2114	2006;108:2114	NUM
ct-9227	31	3	-	-	SYM
ct-9227	31	4	2120	2120	NUM
ct-9227	31	5	.	.	PUNCT
ct-9227	32	1	5	5	X
ct-9227	32	2	.	.	X
ct-9227	32	3	joswig	joswig	PROPN
ct-9227	32	4	a	a	PRON
ct-9227	32	5	,	,	PUNCT
ct-9227	32	6	mitchell	mitchell	PROPN
ct-9227	32	7	a	a	PROPN
ct-9227	32	8	,	,	PUNCT
ct-9227	32	9	cummings	cummings	PROPN
ct-9227	32	10	kj	kj	PROPN
ct-9227	32	11	,	,	PUNCT
ct-9227	32	12	et	et	PROPN
ct-9227	32	13	al	al	PROPN
ct-9227	32	14	:	:	PUNCT
ct-9227	32	15	repeated	repeat	VERB
ct-9227	32	16	intra	intra	ADJ
ct-9227	32	17	-	-	ADJ
ct-9227	32	18	articular	articular	ADJ
ct-9227	32	19	injection	injection	NOUN
ct-9227	32	20	of	of	ADP
ct-9227	32	21	allogeneic	allogeneic	ADJ
ct-9227	32	22	mesenchymal	mesenchymal	NOUN
ct-9227	32	23	stem	stem	NOUN
ct-9227	32	24	cells	cell	NOUN
ct-9227	32	25	causes	cause	VERB
ct-9227	32	26	an	an	DET
ct-9227	32	27	adverse	adverse	ADJ
ct-9227	32	28	response	response	NOUN
ct-9227	32	29	compared	compare	VERB
ct-9227	32	30	to	to	ADP
ct-9227	32	31	autologous	autologous	ADJ
ct-9227	32	32	cells	cell	NOUN
ct-9227	32	33	in	in	ADP
ct-9227	32	34	the	the	DET
ct-9227	32	35	equine	equine	NOUN
ct-9227	32	36	model	model	NOUN
ct-9227	32	37	.	.	PUNCT
ct-9227	33	1	stem	stem	NOUN
ct-9227	33	2	cell	cell	NOUN
ct-9227	33	3	res	re	NOUN
ct-9227	33	4	ther	ther	ADV
ct-9227	33	5	2017;8:42	2017;8:42	NOUN
ct-9227	33	6	.	.	PUNCT
ct-9227	34	1	6	6	X
ct-9227	34	2	.	.	X
ct-9227	34	3	ankrum	ankrum	PROPN
ct-9227	34	4	ja	ja	PROPN
ct-9227	34	5	,	,	PUNCT
ct-9227	34	6	ong	ong	PROPN
ct-9227	34	7	jf	jf	PROPN
ct-9227	34	8	,	,	PUNCT
ct-9227	34	9	karp	karp	PROPN
ct-9227	34	10	jm	jm	PROPN
ct-9227	34	11	:	:	PUNCT
ct-9227	34	12	mesenchymal	mesenchymal	ADJ
ct-9227	34	13	stem	stem	NOUN
ct-9227	34	14	cells	cell	NOUN
ct-9227	34	15	:	:	PUNCT
ct-9227	34	16	immune	immune	ADJ
ct-9227	34	17	evasive	evasive	ADJ
ct-9227	34	18	,	,	PUNCT
ct-9227	34	19	not	not	PART
ct-9227	34	20	immune	immune	ADJ
ct-9227	34	21	privileged	privileged	ADJ
ct-9227	34	22	.	.	PUNCT
ct-9227	35	1	nat	nat	PROPN
ct-9227	35	2	biotechnol	biotechnol	NOUN
ct-9227	35	3	2014	2014	NUM
ct-9227	35	4	32:252	32:252	NUM
ct-9227	35	5	-	-	SYM
ct-9227	35	6	260	260	NUM
ct-9227	35	7	.	.	PUNCT
ct-9227	36	1	7	7	X
ct-9227	36	2	.	.	X
ct-9227	36	3	paterson	paterson	PROPN
ct-9227	36	4	yz	yz	PROPN
ct-9227	36	5	,	,	PUNCT
ct-9227	36	6	rash	rash	NOUN
ct-9227	36	7	n	n	CCONJ
ct-9227	36	8	,	,	PUNCT
ct-9227	36	9	garvican	garvican	PROPN
ct-9227	36	10	er	er	INTJ
ct-9227	36	11	,	,	PUNCT
ct-9227	36	12	et	et	PROPN
ct-9227	36	13	al	al	PROPN
ct-9227	36	14	:	:	PUNCT
ct-9227	36	15	equine	equine	NOUN
ct-9227	36	16	mesenchymal	mesenchymal	ADJ
ct-9227	36	17	stromal	stromal	ADJ
ct-9227	36	18	cells	cell	NOUN
ct-9227	36	19	and	and	CCONJ
ct-9227	36	20	embryo	embryo	NOUN
ct-9227	36	21	-	-	PUNCT
ct-9227	36	22	derived	derive	VERB
ct-9227	36	23	stem	stem	NOUN
ct-9227	36	24	cells	cell	NOUN
ct-9227	36	25	are	be	AUX
ct-9227	36	26	immune	immune	ADJ
ct-9227	36	27	privileged	privileged	ADJ
ct-9227	36	28	in	in	ADP
ct-9227	36	29	vitro	vitro	X
ct-9227	36	30	.	.	PUNCT
ct-9227	37	1	stem	stem	NOUN
ct-9227	37	2	cell	cell	NOUN
ct-9227	37	3	res	re	NOUN
ct-9227	37	4	ther	ther	ADJ
ct-9227	37	5	2014;5:90	2014;5:90	NOUN
ct-9227	37	6	.	.	PUNCT
ct-9227	38	1	8	8	X
ct-9227	38	2	.	.	X
ct-9227	39	1	pigott	pigott	PROPN
ct-9227	39	2	jh	jh	PROPN
ct-9227	39	3	,	,	PUNCT
ct-9227	39	4	ishihara	ishihara	PROPN
ct-9227	39	5	a	a	X
ct-9227	39	6	,	,	PUNCT
ct-9227	39	7	wellman	wellman	NOUN
ct-9227	39	8	ml	ml	ADP
ct-9227	39	9	,	,	PUNCT
ct-9227	39	10	et	et	PROPN
ct-9227	39	11	al	al	PROPN
ct-9227	39	12	:	:	PUNCT
ct-9227	39	13	inflammatory	inflammatory	ADJ
ct-9227	39	14	effects	effect	NOUN
ct-9227	39	15	of	of	ADP
ct-9227	39	16	autologous	autologous	ADJ
ct-9227	39	17	,	,	PUNCT
ct-9227	39	18	genetically	genetically	ADV
ct-9227	39	19	modified	modify	VERB
ct-9227	39	20	autologous	autologous	ADJ
ct-9227	39	21	,	,	PUNCT
ct-9227	39	22	allogeneic	allogeneic	ADJ
ct-9227	39	23	,	,	PUNCT
ct-9227	39	24	and	and	CCONJ
ct-9227	39	25	xenogeneic	xenogeneic	VERB
ct-9227	39	26	mesenchymal	mesenchymal	NOUN
ct-9227	39	27	stem	stem	NOUN
ct-9227	39	28	cells	cell	NOUN
ct-9227	39	29	after	after	ADP
ct-9227	39	30	intra	intra	ADJ
ct-9227	39	31	-	-	ADJ
ct-9227	39	32	articular	articular	ADJ
ct-9227	39	33	injection	injection	NOUN
ct-9227	39	34	in	in	ADP
ct-9227	39	35	horses	horse	NOUN
ct-9227	39	36	.	.	PUNCT
ct-9227	40	1	vet	vet	NOUN
ct-9227	40	2	comp	comp	NOUN
ct-9227	40	3	orthop	orthop	NOUN
ct-9227	40	4	traumatol	traumatol	NOUN
ct-9227	40	5	2013;26:453	2013;26:453	NUM
ct-9227	40	6	-	-	NUM
ct-9227	40	7	460	460	NUM
ct-9227	40	8	.	.	NOUN
ct-9227	41	1	9	9	NUM
ct-9227	41	2	.	.	X
ct-9227	41	3	ferris	ferris	PROPN
ct-9227	41	4	dj	dj	PROPN
ct-9227	41	5	,	,	PUNCT
ct-9227	41	6	frisbie	frisbie	PROPN
ct-9227	41	7	dd	dd	PROPN
ct-9227	41	8	,	,	PUNCT
ct-9227	41	9	kisiday	kisiday	PROPN
ct-9227	41	10	jd	jd	PROPN
ct-9227	41	11	,	,	PUNCT
ct-9227	41	12	et	et	PROPN
ct-9227	41	13	al	al	PROPN
ct-9227	41	14	:	:	PUNCT
ct-9227	41	15	clinical	clinical	ADJ
ct-9227	41	16	outcome	outcome	NOUN
ct-9227	41	17	after	after	ADP
ct-9227	41	18	intra	intra	ADJ
ct-9227	41	19	-	-	ADJ
ct-9227	41	20	articular	articular	ADJ
ct-9227	41	21	administration	administration	NOUN
ct-9227	41	22	of	of	ADP
ct-9227	41	23	bone	bone	NOUN
ct-9227	41	24	marrow	marrow	NOUN
ct-9227	41	25	derived	derive	VERB
ct-9227	41	26	mesenchymal	mesenchymal	NOUN
ct-9227	41	27	stem	stem	NOUN
ct-9227	41	28	cells	cell	NOUN
ct-9227	41	29	in	in	ADP
ct-9227	41	30	33	33	NUM
ct-9227	41	31	horses	horse	NOUN
ct-9227	41	32	with	with	ADP
ct-9227	41	33	stifle	stifle	ADJ
ct-9227	41	34	injury	injury	NOUN
ct-9227	41	35	.	.	PUNCT
ct-9227	42	1	vet	vet	NOUN
ct-9227	42	2	surg	surg	NOUN
ct-9227	42	3	2014:43:255	2014:43:255	NUM
ct-9227	42	4	-	-	SYM
ct-9227	42	5	265	265	NUM
ct-9227	42	6	.	.	PUNCT
ct-9227	43	1	10	10	NUM
ct-9227	43	2	.	.	PUNCT
ct-9227	44	1	pezzanite	pezzanite	PROPN
ct-9227	44	2	lm	lm	PROPN
ct-9227	44	3	,	,	PUNCT
ct-9227	44	4	fortier	fortier	PROPN
ct-9227	44	5	la	la	PROPN
ct-9227	44	6	,	,	PUNCT
ct-9227	44	7	antczak	antczak	VERB
ct-9227	44	8	df	df	PROPN
ct-9227	44	9	,	,	PUNCT
ct-9227	44	10	et	et	PROPN
ct-9227	44	11	al	al	PROPN
ct-9227	44	12	:	:	PUNCT
ct-9227	44	13	equine	equine	NOUN
ct-9227	44	14	allogeneic	allogeneic	ADJ
ct-9227	44	15	bone	bone	NOUN
ct-9227	44	16	marrow	marrow	NOUN
ct-9227	44	17	-	-	PUNCT
ct-9227	44	18	derived	derive	VERB
ct-9227	44	19	mesenchymal	mesenchymal	ADJ
ct-9227	44	20	stromal	stromal	ADJ
ct-9227	44	21	cells	cell	NOUN
ct-9227	44	22	elicit	elicit	VERB
ct-9227	44	23	antibody	antibody	NOUN
ct-9227	44	24	responses	response	NOUN
ct-9227	44	25	in	in	ADP
ct-9227	44	26	vivo	vivo	NOUN
ct-9227	44	27	.	.	PUNCT
ct-9227	45	1	stem	stem	NOUN
ct-9227	45	2	cell	cell	NOUN
ct-9227	45	3	res	re	NOUN
ct-9227	45	4	ther	ther	ADJ
ct-9227	45	5	2015;6:54	2015;6:54	NOUN
ct-9227	45	6	.	.	PUNCT
ct-9227	46	1	clinical	clinical	ADJ
ct-9227	46	2	theriogenology	theriogenology	NOUN
ct-9227	46	3	•	•	NOUN
ct-9227	46	4	volume	volume	NOUN
ct-9227	46	5	12	12	NUM
ct-9227	46	6	number	number	NOUN
ct-9227	46	7	3	3	NUM
ct-9227	46	8	•	•	NUM
ct-9227	46	9	september	september	PROPN
ct-9227	46	10	2020	2020	NUM
ct-9227	46	11	181	181	NUM
ct-9227	46	12	11	11	NUM
ct-9227	46	13	.	.	PUNCT
ct-9227	47	1	berglund	berglund	PROPN
ct-9227	47	2	ak	ak	PROPN
ct-9227	47	3	,	,	PUNCT
ct-9227	47	4	schnabel	schnabel	PROPN
ct-9227	47	5	lv	lv	PROPN
ct-9227	47	6	:	:	PUNCT
ct-9227	47	7	allogeneic	allogeneic	VERB
ct-9227	47	8	major	major	ADJ
ct-9227	47	9	histocompatibility	histocompatibility	NOUN
ct-9227	47	10	complex	complex	NOUN
ct-9227	47	11	-	-	PUNCT
ct-9227	47	12	mismatched	mismatch	VERB
ct-9227	47	13	equine	equine	NOUN
ct-9227	47	14	bone	bone	NOUN
ct-9227	47	15	marrow	marrow	NOUN
ct-9227	47	16	-	-	PUNCT
ct-9227	47	17	derived	derive	VERB
ct-9227	47	18	mesenchymal	mesenchymal	NOUN
ct-9227	47	19	stem	stem	NOUN
ct-9227	47	20	cells	cell	NOUN
ct-9227	47	21	are	be	AUX
ct-9227	47	22	targeted	target	VERB
ct-9227	47	23	for	for	ADP
ct-9227	47	24	death	death	NOUN
ct-9227	47	25	by	by	ADP
ct-9227	47	26	cytotoxic	cytotoxic	ADJ
ct-9227	47	27	anti	anti	ADJ
ct-9227	47	28	-	-	ADJ
ct-9227	47	29	major	major	ADJ
ct-9227	47	30	histocompatibility	histocompatibility	NOUN
ct-9227	47	31	complex	complex	NOUN
ct-9227	47	32	antibodies	antibodie	VERB
ct-9227	47	33	.	.	PUNCT
ct-9227	48	1	equine	equine	NOUN
ct-9227	48	2	vet	vet	NOUN
ct-9227	48	3	j	j	PROPN
ct-9227	48	4	2017;49:539	2017;49:539	NOUN
ct-9227	48	5	-	-	PUNCT
ct-9227	48	6	544	544	NUM
ct-9227	48	7	.	.	NOUN
ct-9227	48	8	12	12	NUM
ct-9227	48	9	.	.	PUNCT
ct-9227	49	1	jevotovsky	jevotovsky	PROPN
ct-9227	49	2	ds	ds	PROPN
ct-9227	49	3	,	,	PUNCT
ct-9227	49	4	alfonso	alfonso	PROPN
ct-9227	49	5	ar	ar	PROPN
ct-9227	49	6	,	,	PUNCT
ct-9227	49	7	einhorn	einhorn	PROPN
ct-9227	49	8	ta	ta	PROPN
ct-9227	49	9	,	,	PUNCT
ct-9227	49	10	et	et	PROPN
ct-9227	49	11	al	al	PROPN
ct-9227	49	12	:	:	PUNCT
ct-9227	49	13	osteoarthritis	osteoarthritis	NOUN
ct-9227	49	14	and	and	CCONJ
ct-9227	49	15	stem	stem	NOUN
ct-9227	49	16	cell	cell	NOUN
ct-9227	49	17	therapy	therapy	NOUN
ct-9227	49	18	in	in	ADP
ct-9227	49	19	humans	human	NOUN
ct-9227	49	20	:	:	PUNCT
ct-9227	49	21	a	a	DET
ct-9227	49	22	systematic	systematic	ADJ
ct-9227	49	23	review	review	NOUN
ct-9227	49	24	.	.	PUNCT
ct-9227	50	1	osteoarthr	osteoarthr	PROPN
ct-9227	50	2	cartil	cartil	ADP
ct-9227	50	3	2018;26:711	2018;26:711	PROPN
ct-9227	50	4	-	-	SYM
ct-9227	50	5	729	729	NUM
ct-9227	50	6	.	.	PUNCT
ct-9227	51	1	13	13	NUM
ct-9227	51	2	.	.	PUNCT
ct-9227	52	1	barry	barry	PROPN
ct-9227	52	2	f	f	PROPN
ct-9227	52	3	:	:	PUNCT
ct-9227	52	4	msc	msc	PROPN
ct-9227	52	5	therapy	therapy	NOUN
ct-9227	52	6	for	for	ADP
ct-9227	52	7	osteoarthritis	osteoarthritis	NOUN
ct-9227	52	8	:	:	PUNCT
ct-9227	52	9	an	an	DET
ct-9227	52	10	unfinished	unfinished	ADJ
ct-9227	52	11	story	story	NOUN
ct-9227	52	12	.	.	PUNCT
ct-9227	53	1	j	j	PROPN
ct-9227	53	2	orthop	orthop	PROPN
ct-9227	53	3	res	re	VERB
ct-9227	53	4	2019;37:1229	2019;37:1229	NUM
ct-9227	53	5	-	-	SYM
ct-9227	53	6	1235	1235	NUM
ct-9227	53	7	.	.	PUNCT
ct-9227	54	1	14	14	NUM
ct-9227	54	2	.	.	PUNCT
ct-9227	55	1	friedenstein	friedenstein	PROPN
ct-9227	55	2	aj	aj	PROPN
ct-9227	55	3	,	,	PUNCT
ct-9227	55	4	chailakhjan	chailakhjan	PROPN
ct-9227	55	5	rk	rk	PROPN
ct-9227	55	6	,	,	PUNCT
ct-9227	55	7	lalykina	lalykina	VERB
ct-9227	55	8	ks	ks	NOUN
ct-9227	55	9	:	:	PUNCT
ct-9227	55	10	the	the	DET
ct-9227	55	11	development	development	NOUN
ct-9227	55	12	of	of	ADP
ct-9227	55	13	fibroblast	fibroblast	ADJ
ct-9227	55	14	colonies	colony	NOUN
ct-9227	55	15	in	in	ADP
ct-9227	55	16	monolayer	monolayer	NOUN
ct-9227	55	17	cultures	culture	NOUN
ct-9227	55	18	of	of	ADP
ct-9227	55	19	guinea	guinea	NOUN
ct-9227	55	20	-	-	PUNCT
ct-9227	55	21	pig	pig	NOUN
ct-9227	55	22	bone	bone	NOUN
ct-9227	55	23	marrow	marrow	NOUN
ct-9227	55	24	and	and	CCONJ
ct-9227	55	25	spleen	spleen	NOUN
ct-9227	55	26	cells	cell	NOUN
ct-9227	55	27	.	.	PUNCT
ct-9227	56	1	cell	cell	NOUN
ct-9227	56	2	tissue	tissue	NOUN
ct-9227	56	3	kinet	kinet	PROPN
ct-9227	56	4	1970;3:393	1970;3:393	PROPN
ct-9227	56	5	-	-	SYM
ct-9227	56	6	403	403	NUM
ct-9227	56	7	.	.	PUNCT
ct-9227	56	8	15	15	X
ct-9227	56	9	.	.	X
ct-9227	57	1	selvaggi	selvaggi	PROPN
ct-9227	57	2	ta	ta	PROPN
ct-9227	57	3	,	,	PUNCT
ct-9227	57	4	walker	walker	PROPN
ct-9227	57	5	re	re	PROPN
ct-9227	57	6	,	,	PUNCT
ct-9227	57	7	fleisher	fleisher	PROPN
ct-9227	57	8	ta	ta	PROPN
ct-9227	57	9	:	:	PUNCT
ct-9227	57	10	development	development	NOUN
ct-9227	57	11	of	of	ADP
ct-9227	57	12	antibodies	antibody	NOUN
ct-9227	57	13	to	to	PART
ct-9227	57	14	fetal	fetal	ADJ
ct-9227	57	15	calf	calf	NOUN
ct-9227	57	16	serum	serum	NOUN
ct-9227	57	17	with	with	ADP
ct-9227	57	18	arthus	arthus	NOUN
ct-9227	57	19	-	-	PUNCT
ct-9227	57	20	like	like	ADJ
ct-9227	57	21	reactions	reaction	NOUN
ct-9227	57	22	in	in	ADP
ct-9227	57	23	human	human	ADJ
ct-9227	57	24	immunodeficiency	immunodeficiency	NOUN
ct-9227	57	25	virus	virus	NOUN
ct-9227	57	26	-	-	PUNCT
ct-9227	57	27	infected	infect	VERB
ct-9227	57	28	patients	patient	NOUN
ct-9227	57	29	given	give	VERB
ct-9227	57	30	syngeneic	syngeneic	VERB
ct-9227	57	31	lymphocyte	lymphocyte	ADJ
ct-9227	57	32	infusions	infusion	NOUN
ct-9227	57	33	.	.	PUNCT
ct-9227	58	1	blood	blood	NOUN
ct-9227	58	2	1997;89:776	1997;89:776	PROPN
ct-9227	58	3	-	-	SYM
ct-9227	58	4	779	779	NUM
ct-9227	58	5	.	.	PROPN
ct-9227	58	6	16	16	NUM
ct-9227	58	7	.	.	PUNCT
ct-9227	59	1	macy	macy	PROPN
ct-9227	59	2	e	e	PROPN
ct-9227	59	3	,	,	PUNCT
ct-9227	59	4	bulpitt	bulpitt	PROPN
ct-9227	59	5	k	k	PROPN
ct-9227	59	6	,	,	PUNCT
ct-9227	59	7	champlin	champlin	PROPN
ct-9227	59	8	re	re	PROPN
ct-9227	59	9	,	,	PUNCT
ct-9227	59	10	et	et	PROPN
ct-9227	59	11	al	al	PROPN
ct-9227	59	12	:	:	PUNCT
ct-9227	59	13	anaphylaxis	anaphylaxis	ADJ
ct-9227	59	14	to	to	ADP
ct-9227	59	15	infusion	infusion	NOUN
ct-9227	59	16	of	of	ADP
ct-9227	59	17	autologous	autologous	ADJ
ct-9227	59	18	bone	bone	NOUN
ct-9227	59	19	marrow	marrow	NOUN
ct-9227	59	20	:	:	PUNCT
ct-9227	59	21	an	an	DET
ct-9227	59	22	apparent	apparent	ADJ
ct-9227	59	23	reaction	reaction	NOUN
ct-9227	59	24	to	to	ADP
ct-9227	59	25	self	self	NOUN
ct-9227	59	26	,	,	PUNCT
ct-9227	59	27	mediated	mediate	VERB
ct-9227	59	28	by	by	ADP
ct-9227	59	29	ige	ige	PROPN
ct-9227	59	30	antibody	antibody	NOUN
ct-9227	59	31	to	to	PART
ct-9227	59	32	bovine	bovine	VERB
ct-9227	59	33	serum	serum	NOUN
ct-9227	59	34	albumin	albumin	PROPN
ct-9227	59	35	.	.	PUNCT
ct-9227	60	1	j	j	PROPN
ct-9227	60	2	allergy	allergy	PROPN
ct-9227	60	3	clin	clin	PROPN
ct-9227	60	4	immunol	immunol	PROPN
ct-9227	60	5	1989;83:871	1989;83:871	PROPN
ct-9227	60	6	-	-	PUNCT
ct-9227	60	7	875	875	NUM
ct-9227	60	8	.	.	PUNCT
ct-9227	60	9	17	17	NUM
ct-9227	60	10	.	.	PUNCT
ct-9227	61	1	sundin	sundin	PROPN
ct-9227	61	2	m	m	PROPN
ct-9227	61	3	,	,	PUNCT
ct-9227	61	4	ringdén	ringdén	PROPN
ct-9227	61	5	o	o	PROPN
ct-9227	61	6	,	,	PUNCT
ct-9227	61	7	sundberg	sundberg	PROPN
ct-9227	61	8	b	b	PROPN
ct-9227	61	9	,	,	PUNCT
ct-9227	61	10	et	et	PROPN
ct-9227	61	11	al	al	PROPN
ct-9227	61	12	:	:	PUNCT
ct-9227	61	13	no	no	DET
ct-9227	61	14	alloantibodies	alloantibody	NOUN
ct-9227	61	15	against	against	ADP
ct-9227	61	16	mesenchymal	mesenchymal	ADJ
ct-9227	61	17	stromal	stromal	ADJ
ct-9227	61	18	cells	cell	NOUN
ct-9227	61	19	,	,	PUNCT
ct-9227	61	20	but	but	CCONJ
ct-9227	61	21	presence	presence	NOUN
ct-9227	61	22	of	of	ADP
ct-9227	61	23	antifetal	antifetal	ADJ
ct-9227	61	24	calf	calf	NOUN
ct-9227	61	25	serum	serum	NOUN
ct-9227	61	26	antibodies	antibodie	VERB
ct-9227	61	27	,	,	PUNCT
ct-9227	61	28	after	after	ADP
ct-9227	61	29	transplantation	transplantation	NOUN
ct-9227	61	30	in	in	ADP
ct-9227	61	31	allogeneic	allogeneic	ADJ
ct-9227	61	32	hematopoietic	hematopoietic	ADJ
ct-9227	61	33	stem	stem	NOUN
ct-9227	61	34	cell	cell	NOUN
ct-9227	61	35	recipients	recipient	NOUN
ct-9227	61	36	.	.	PUNCT
ct-9227	62	1	haematologica	haematologica	PROPN
ct-9227	62	2	2007;92:1208	2007;92:1208	NUM
ct-9227	62	3	-	-	SYM
ct-9227	62	4	1215	1215	NUM
ct-9227	62	5	.	.	PUNCT
ct-9227	63	1	18	18	NUM
ct-9227	63	2	.	.	PUNCT
ct-9227	64	1	horwitz	horwitz	PROPN
ct-9227	64	2	em	em	PRON
ct-9227	64	3	,	,	PUNCT
ct-9227	64	4	gordon	gordon	PROPN
ct-9227	64	5	pl	pl	PROPN
ct-9227	64	6	,	,	PUNCT
ct-9227	64	7	koo	koo	PROPN
ct-9227	64	8	wk	wk	PROPN
ct-9227	64	9	,	,	PUNCT
ct-9227	64	10	et	et	PROPN
ct-9227	64	11	al	al	PROPN
ct-9227	64	12	:	:	PUNCT
ct-9227	64	13	isolated	isolated	ADJ
ct-9227	64	14	allogeneic	allogeneic	ADJ
ct-9227	64	15	bone	bone	NOUN
ct-9227	64	16	marrow	marrow	NOUN
ct-9227	64	17	-	-	PUNCT
ct-9227	64	18	derived	derive	VERB
ct-9227	64	19	mesenchymal	mesenchymal	NOUN
ct-9227	64	20	cells	cell	NOUN
ct-9227	64	21	engraft	engraft	VERB
ct-9227	64	22	and	and	CCONJ
ct-9227	64	23	stimulate	stimulate	VERB
ct-9227	64	24	growth	growth	NOUN
ct-9227	64	25	in	in	ADP
ct-9227	64	26	children	child	NOUN
ct-9227	64	27	with	with	ADP
ct-9227	64	28	osteogenesis	osteogenesis	NOUN
ct-9227	64	29	imperfecta	imperfecta	NOUN
ct-9227	64	30	:	:	PUNCT
ct-9227	64	31	implications	implication	NOUN
ct-9227	64	32	for	for	ADP
ct-9227	64	33	cell	cell	NOUN
ct-9227	64	34	therapy	therapy	NOUN
ct-9227	64	35	of	of	ADP
ct-9227	64	36	bone	bone	NOUN
ct-9227	64	37	.	.	PUNCT
ct-9227	65	1	proc	proc	PROPN
ct-9227	65	2	natl	natl	PROPN
ct-9227	65	3	acad	acad	PROPN
ct-9227	65	4	sci	sci	PROPN
ct-9227	65	5	u	u	PROPN
ct-9227	65	6	s	s	NOUN
ct-9227	65	7	a.	a.	NOUN
ct-9227	65	8	2002;99:8932	2002;99:8932	PROPN
ct-9227	65	9	-	-	SYM
ct-9227	65	10	8937	8937	NUM
ct-9227	65	11	.	.	PUNCT
ct-9227	66	1	19	19	NUM
ct-9227	66	2	.	.	X
ct-9227	66	3	galipeau	galipeau	PROPN
ct-9227	66	4	j	j	PROPN
ct-9227	66	5	,	,	PUNCT
ct-9227	66	6	sensébé	sensébé	PROPN
ct-9227	66	7	l	l	NOUN
ct-9227	66	8	:	:	PUNCT
ct-9227	66	9	mesenchymal	mesenchymal	ADJ
ct-9227	66	10	stromal	stromal	ADJ
ct-9227	66	11	cells	cell	NOUN
ct-9227	66	12	:	:	PUNCT
ct-9227	66	13	clinical	clinical	ADJ
ct-9227	66	14	challenges	challenge	NOUN
ct-9227	66	15	and	and	CCONJ
ct-9227	66	16	therapeutic	therapeutic	ADJ
ct-9227	66	17	opportunities	opportunity	NOUN
ct-9227	66	18	.	.	PUNCT
ct-9227	67	1	cell	cell	NOUN
ct-9227	67	2	stem	stem	NOUN
ct-9227	67	3	cell	cell	NOUN
ct-9227	67	4	2018;22:824	2018;22:824	NOUN
ct-9227	67	5	-	-	SYM
ct-9227	67	6	833	833	NUM
ct-9227	67	7	.	.	PUNCT
ct-9227	68	1	20	20	NUM
ct-9227	68	2	.	.	X
ct-9227	68	3	jonsdottir	jonsdottir	NOUN
ct-9227	68	4	-	-	PUNCT
ct-9227	68	5	buch	buch	NOUN
ct-9227	68	6	sm	sm	PROPN
ct-9227	68	7	,	,	PUNCT
ct-9227	68	8	lieder	lieder	NOUN
ct-9227	68	9	r	r	NOUN
ct-9227	68	10	,	,	PUNCT
ct-9227	68	11	sigurjonsson	sigurjonsson	NOUN
ct-9227	68	12	oe	oe	PROPN
ct-9227	68	13	:	:	PUNCT
ct-9227	68	14	platelet	platelet	NOUN
ct-9227	68	15	lysates	lysate	NOUN
ct-9227	68	16	produced	produce	VERB
ct-9227	68	17	from	from	ADP
ct-9227	68	18	expired	expire	VERB
ct-9227	68	19	platelet	platelet	NOUN
ct-9227	68	20	concentrates	concentrate	VERB
ct-9227	68	21	support	support	VERB
ct-9227	68	22	growth	growth	NOUN
ct-9227	68	23	and	and	CCONJ
ct-9227	68	24	osteogenic	osteogenic	ADJ
ct-9227	68	25	differentiation	differentiation	NOUN
ct-9227	68	26	of	of	ADP
ct-9227	68	27	mesenchymal	mesenchymal	ADJ
ct-9227	68	28	stem	stem	NOUN
ct-9227	68	29	cells	cell	NOUN
ct-9227	68	30	.	.	PUNCT
ct-9227	69	1	plos	plos	PROPN
ct-9227	69	2	one	one	NUM
ct-9227	69	3	2013;8	2013;8	NUM
ct-9227	69	4	:	:	PUNCT
ct-9227	69	5	e68984	e68984	PROPN
ct-9227	69	6	.	.	PUNCT
ct-9227	70	1	21	21	NUM
ct-9227	70	2	.	.	PUNCT
ct-9227	71	1	shetty	shetty	PROPN
ct-9227	71	2	p	p	PROPN
ct-9227	71	3	,	,	PUNCT
ct-9227	71	4	bharucha	bharucha	PROPN
ct-9227	71	5	k	k	NOUN
ct-9227	71	6	,	,	PUNCT
ct-9227	71	7	tanavde	tanavde	ADJ
ct-9227	71	8	v	v	NOUN
ct-9227	71	9	:	:	PUNCT
ct-9227	71	10	human	human	ADJ
ct-9227	71	11	umbilical	umbilical	ADJ
ct-9227	71	12	cord	cord	NOUN
ct-9227	71	13	blood	blood	NOUN
ct-9227	71	14	serum	serum	NOUN
ct-9227	71	15	can	can	AUX
ct-9227	71	16	replace	replace	VERB
ct-9227	71	17	fetal	fetal	ADJ
ct-9227	71	18	bovine	bovine	NOUN
ct-9227	71	19	serum	serum	NOUN
ct-9227	71	20	in	in	ADP
ct-9227	71	21	the	the	DET
ct-9227	71	22	culture	culture	NOUN
ct-9227	71	23	of	of	ADP
ct-9227	71	24	mesenchymal	mesenchymal	ADJ
ct-9227	71	25	stem	stem	NOUN
ct-9227	71	26	cells	cell	NOUN
ct-9227	71	27	.	.	PUNCT
ct-9227	72	1	cell	cell	NOUN
ct-9227	72	2	biol	biol	PROPN
ct-9227	72	3	int	int	PROPN
ct-9227	72	4	2007;3:293	2007;3:293	NUM
ct-9227	72	5	-	-	SYM
ct-9227	72	6	298	298	NUM
ct-9227	72	7	.	.	PUNCT
ct-9227	73	1	22	22	NUM
ct-9227	73	2	.	.	PUNCT
ct-9227	74	1	abbuehl	abbuehl	PROPN
ct-9227	74	2	j	j	PROPN
ct-9227	74	3	,	,	PUNCT
ct-9227	74	4	tatarova	tatarova	PROPN
ct-9227	74	5	z	z	NOUN
ct-9227	74	6	,	,	PUNCT
ct-9227	74	7	held	hold	VERB
ct-9227	74	8	w	w	NOUN
ct-9227	74	9	:	:	PUNCT
ct-9227	74	10	long	long	ADJ
ct-9227	74	11	-	-	PUNCT
ct-9227	74	12	term	term	NOUN
ct-9227	74	13	engraftment	engraftment	NOUN
ct-9227	74	14	of	of	ADP
ct-9227	74	15	primary	primary	ADJ
ct-9227	74	16	bone	bone	NOUN
ct-9227	74	17	marrow	marrow	NOUN
ct-9227	74	18	stromal	stromal	ADJ
ct-9227	74	19	cells	cell	NOUN
ct-9227	74	20	repairs	repair	VERB
ct-9227	74	21	niche	niche	NOUN
ct-9227	74	22	damage	damage	NOUN
ct-9227	74	23	and	and	CCONJ
ct-9227	74	24	improves	improve	VERB
ct-9227	74	25	hematopoietic	hematopoietic	ADJ
ct-9227	74	26	stem	stem	NOUN
ct-9227	74	27	cell	cell	NOUN
ct-9227	74	28	transplantation	transplantation	NOUN
ct-9227	74	29	.	.	PUNCT
ct-9227	75	1	cell	cell	NOUN
ct-9227	75	2	stem	stem	NOUN
ct-9227	75	3	cell	cell	NOUN
ct-9227	75	4	2017	2017	NUM
ct-9227	75	5	21:255.e6	21:255.e6	NUM
ct-9227	75	6	.	.	PUNCT
ct-9227	76	1	23	23	NUM
ct-9227	76	2	.	.	PUNCT
ct-9227	77	1	longhini	longhini	PROPN
ct-9227	77	2	alf	alf	PROPN
ct-9227	77	3	,	,	PUNCT
ct-9227	77	4	salazar	salazar	NOUN
ct-9227	77	5	te	te	PROPN
ct-9227	77	6	,	,	PUNCT
ct-9227	77	7	vieira	vieira	PROPN
ct-9227	77	8	c	c	PROPN
ct-9227	77	9	,	,	PUNCT
ct-9227	77	10	et	et	PROPN
ct-9227	77	11	al	al	PROPN
ct-9227	77	12	:	:	PUNCT
ct-9227	77	13	peripheral	peripheral	ADJ
ct-9227	77	14	blood	blood	NOUN
ct-9227	77	15	-	-	PUNCT
ct-9227	77	16	derived	derive	VERB
ct-9227	77	17	mesenchymal	mesenchymal	NOUN
ct-9227	77	18	stem	stem	NOUN
ct-9227	77	19	cells	cell	NOUN
ct-9227	77	20	demonstrate	demonstrate	VERB
ct-9227	77	21	immunomodulatory	immunomodulatory	ADJ
ct-9227	77	22	potential	potential	NOUN
ct-9227	77	23	for	for	ADP
ct-9227	77	24	therapeutic	therapeutic	ADJ
ct-9227	77	25	use	use	NOUN
ct-9227	77	26	in	in	ADP
ct-9227	77	27	horses	horse	NOUN
ct-9227	77	28	.	.	PUNCT
ct-9227	78	1	plos	plos	PROPN
ct-9227	78	2	one	one	NUM
ct-9227	78	3	2019;14	2019;14	NUM
ct-9227	78	4	:	:	PUNCT
ct-9227	78	5	e0212642	e0212642	NUM
ct-9227	78	6	.	.	PUNCT
ct-9227	79	1	clinical	clinical	ADJ
ct-9227	79	2	theriogenology	theriogenology	NOUN
ct-9227	79	3	•	•	NOUN
ct-9227	79	4	volume	volume	NOUN
ct-9227	79	5	12	12	NUM
ct-9227	79	6	number	number	NOUN
ct-9227	79	7	3	3	NUM
ct-9227	79	8	•	•	NUM
ct-9227	79	9	september	september	PROPN
ct-9227	79	10	2020182	2020182	NUM
ct-9227	79	11	007_ms-007	007_ms-007	PUNCT
ct-9227	79	12	watts	watt	VERB